These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
219 related items for PubMed ID: 31658964
1. New Antifungal Susceptibility Test Based on Chitin Detection by Image Cytometry. Wang Y, Andriampamonjy AN, Bailly S, Garnaud C, Maubon D, Cornet M, Aldebert D. Antimicrob Agents Chemother; 2019 Dec 20; 64(1):. PubMed ID: 31658964 [Abstract] [Full Text] [Related]
2. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment. Jensen RH. Dan Med J; 2016 Oct 20; 63(10):. PubMed ID: 27697142 [Abstract] [Full Text] [Related]
3. Candida and candidaemia. Susceptibility and epidemiology. Arendrup MC. Dan Med J; 2013 Nov 20; 60(11):B4698. PubMed ID: 24192246 [Abstract] [Full Text] [Related]
4. In Vitro Antifungal Susceptibility Testing of Candida Isolates with the EUCAST Methodology, a New Method for ECOFF Determination. Meletiadis J, Curfs-Breuker I, Meis JF, Mouton JW. Antimicrob Agents Chemother; 2017 Apr 20; 61(4):. PubMed ID: 28115353 [Abstract] [Full Text] [Related]
5. Proof of Concept for MBT ASTRA, a Rapid Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry (MALDI-TOF MS)-Based Method To Detect Caspofungin Resistance in Candida albicans and Candida glabrata. Vatanshenassan M, Boekhout T, Lass-Flörl C, Lackner M, Schubert S, Kostrzewa M, Sparbier K. J Clin Microbiol; 2018 Sep 20; 56(9):. PubMed ID: 30021820 [Abstract] [Full Text] [Related]
6. Activity of a long-acting echinocandin, CD101, determined using CLSI and EUCAST reference methods, against Candida and Aspergillus spp., including echinocandin- and azole-resistant isolates. Pfaller MA, Messer SA, Rhomberg PR, Jones RN, Castanheira M. J Antimicrob Chemother; 2016 Oct 20; 71(10):2868-73. PubMed ID: 27287236 [Abstract] [Full Text] [Related]
7. Monitoring Antifungal Resistance in a Global Collection of Invasive Yeasts and Molds: Application of CLSI Epidemiological Cutoff Values and Whole-Genome Sequencing Analysis for Detection of Azole Resistance in Candida albicans. Castanheira M, Deshpande LM, Davis AP, Rhomberg PR, Pfaller MA. Antimicrob Agents Chemother; 2017 Oct 20; 61(10):. PubMed ID: 28784671 [Abstract] [Full Text] [Related]
8. Antifungal effects of a 1,3,4-thiadiazole derivative determined by cytochemical and vibrational spectroscopic studies. Chudzik B, Bonio K, Dabrowski W, Pietrzak D, Niewiadomy A, Olender A, Pawlikowska-Pawlęga B, Gagoś M. PLoS One; 2019 Oct 20; 14(9):e0222775. PubMed ID: 31568502 [Abstract] [Full Text] [Related]
9. Analysis of antifungal resistance genes in Candida albicans and Candida glabrata using next generation sequencing. Spettel K, Barousch W, Makristathis A, Zeller I, Nehr M, Selitsch B, Lackner M, Rath PM, Steinmann J, Willinger B. PLoS One; 2019 Oct 20; 14(1):e0210397. PubMed ID: 30629653 [Abstract] [Full Text] [Related]
10. Antifungal susceptibilities of Candida, Cryptococcus neoformans and Aspergillus fumigatus from the Asia and Western Pacific region: data from the SENTRY antifungal surveillance program (2010-2012). Pfaller MA, Messer SA, Jones RN, Castanheira M. J Antibiot (Tokyo); 2015 Sep 20; 68(9):556-61. PubMed ID: 25899126 [Abstract] [Full Text] [Related]